Skip to main content
Signal8

Cobo Marc

SEC insider (Form 3/4/5 filer). CIK 0001816654. Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 21, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Cobo Marc has filed insider reports for

  • BridgeBio Oncology Therapeutics, Inc. (BBOT): Officer, Principal Accounting Officer
Cobo Marc profile photo

Cobo Marc

CIK: 0001816654

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BridgeBio Oncology Therapeutics, Inc. logo
BBOT

BridgeBio Oncology Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • BridgeBio Oncology Therapeutics, Inc. logo
    BBOT

    BridgeBio Oncology Therapeutics, Inc.

    Oct 21, 2026
    Tax Payment
    Direct
    203 shares at avg. $2.68$544.04
  • BridgeBio Oncology Therapeutics, Inc. logo
    BBOT

    BridgeBio Oncology Therapeutics, Inc.

    Oct 1, 2026
    Tax Payment
    Direct
    126 shares at avg. $3.94$496.44
  • BridgeBio Oncology Therapeutics, Inc. logo
    BBOT

    BridgeBio Oncology Therapeutics, Inc.

    Sep 10, 2026
    Award
    Direct
    9K shares-
  • BridgeBio Oncology Therapeutics, Inc. logo
    BBOT

    BridgeBio Oncology Therapeutics, Inc.

    Sep 10, 2026
    Tax Payment
    Direct
    203 shares at avg. $5.52$1K
  • BridgeBio Oncology Therapeutics, Inc. logo
    BBOT

    BridgeBio Oncology Therapeutics, Inc.

    Jul 1, 2026
    Tax Payment
    Direct
    125 shares at avg. $7.80$975

1-5 of 5